A CD25 test is a specialized laboratory assay that measures expression of the CD25 protein, the alpha chain of the interleukin-2 (IL-2) receptor. Predominantly expressed on activated T cells, regulatory T cells (Tregs), and certain neoplastic lymphocytes, this test is commonly performed using flow cytometry or immunohistochemistry on blood, bone marrow, or tissue samples.
It serves as a critical diagnostic tool for identifying specific hematologic malignancies, such as adult T-cell leukemia/lymphoma (ATLL) and hairy cell leukemia. Additionally, elevated CD25 levels assist in monitoring autoimmune diseases, organ transplant rejection, and systemic inflammatory conditions like hemophagocytic lymphohistiocytosis.

A CD23 test is a specialized laboratory assay used to evaluate the expression of the CD23 protein, a low-affinity IgE receptor predominantly found on mature B cells, activated macrophages, and eosinophils. Commonly performed via flow cytometry or immunohistochemistry on blood or tissue samples, this test plays an important role in diagnosing and monitoring B-cell lymphoproliferative disorders, notably Chronic Lymphocytic Leukemia (CLL) where CD23 is characteristically expressed.
Additionally, measuring soluble CD23 levels can aid in assessing allergic disease severity and inflammatory conditions, providing valuable diagnostic and prognostic insight for targeted patient management.

The Cardiolipin Antibody (ACL) - IgM Test is a diagnostic blood test used to detect and measure the levels of IgM class antibodies directed against cardiolipin, a crucial phospholipid found in cell membranes. This test is a key component in the evaluation of Antiphospholipid Syndrome (APS), an autoimmune disorder associated with an increased risk of blood clots (thrombosis) in arteries and veins, as well as pregnancy complications like recurrent miscarriages. While IgG antibodies are more commonly associated with APS, testing for IgM provides additional diagnostic sensitivity, especially in acute phases of the condition. The result helps clinicians assess a patient’s risk profile.

The Cardiolipin Antibody (ACL) - IgA Test is a specialized blood test used to detect IgA class antibodies directed against cardiolipin, a vital phospholipid found in cell membranes.
This test is primarily ordered to aid in the diagnosis of Antiphospholipid Syndrome (APS), an autoimmune disorder characterized by abnormal blood clotting in arteries and veins, as well as recurrent pregnancy complications. While IgG and IgM are the most common isotypes tested, checking for IgA antibodies provides additional diagnostic value, especially in patients with clinical symptoms of APS who test negative for other markers. It helps physicians assess thrombotic risk accurately.

The Carbohydrate-Deficient Transferrin (CDT) test is a specialized blood test primarily used as a biomarker for chronic and heavy alcohol consumption. Transferrin is a protein responsible for transporting iron through the bloodstream, and its molecular structure changes when exposed to sustained, high levels of alcohol over a period of weeks.
Unlike standard liver function tests that can fluctuate due to various medical conditions or medications, CDT is highly specific to alcohol abuse. It is frequently utilized in addiction treatment, forensic evaluations, and clinical settings to monitor sobriety, assess relapse, and evaluate chronic alcohol-induced organ damage effectively.

A gall bladder calculus analysis using automated Fourier Transform Infrared (FTIR) spectroscopy is an advanced laboratory test designed to identify the exact chemical composition of gallstones. When a gallstone is extracted, it is placed into an automated FTIR analyzer, which shines infrared light through the sample. Because different molecular compounds absorb infrared frequencies uniquely, the instrument generates a distinct spectral fingerprint. This analysis precisely determines whether the stone is composed predominantly of cholesterol, pigment (bilirubin), or a mixed composition. Understanding the stone's makeup helps physicians uncover underlying metabolic causes and tailor effective, personalized recurrence prevention strategies.

The CA 72-4 test measures the level of cancer antigen 72-4, a tumor-associated glycoprotein found in the blood. It serves primarily as an adjunct biomarker for evaluating and monitoring gastrointestinal malignancies, most notably gastric (stomach) cancer, as well as tracking potential disease recurrence or treatment efficacy. Additionally, CA 72-4 is sometimes utilized alongside other markers, such as CA 125, in the management of ovarian and other epithelial cancers. Because elevated concentrations can also occur in benign inflammatory conditions, the test is not used for standalone screening and requires correlation with clinical findings.

The bladder mass medium biopsy (1-3 cm test) is a targeted pathological procedure used to evaluate tissue growths measuring between one and three centimeters located within the urinary bladder.
During cystoscopy, a specialist collects a medium-sized tissue sample from the suspicious lesion. This sample undergoes detailed microscopic examination by a pathologist to determine whether the mass is benign or malignant, and to grade its cellular structure.
Accurately diagnosing a bladder mass of this scale is crucial for staging urothelial carcinoma or other conditions, enabling physicians to formulate precise treatment strategies and surgical interventions.

The bilirubin direct test measures the amount of conjugated (water-soluble) bilirubin in your blood. After raw bilirubin is processed and filtered through the liver, it binds with specific sugars, allowing it to dissolve and pass easily into the bile ducts for excretion.
This specific diagnostic test is vital for determining the precise cause of jaundice and evaluating liver or gallbladder health. Elevated levels of direct bilirubin typically point toward a physical blockage within the biliary tract, gallstones, or intrahepatic cholestasis. By pinpointing conjugated bilirubin levels, physicians can quickly differentiate between various hepatic disorders and targeted pathologies.

The bile acids test is a diagnostic blood or fecal examination that measures the concentration of bile acids circulating in the body. Produced by the liver and stored in the gallbladder, bile acids help digest dietary fats and absorb vital nutrients.
This test is primarily used to evaluate liver function, diagnose chronic liver diseases, detect intrahepatic cholestasis of pregnancy, and assess gastrointestinal malabsorption issues. Abnormally elevated or lowered levels can indicate impaired hepatic clearance, biliary tract blockages, or disrupted enterohepatic circulation, providing critical insights for targeted medical intervention.

A **Basic Arthritis Profile for Male** is a targeted blood panel designed to evaluate systemic inflammation and identify markers associated with various arthritic conditions. This profile typically includes tests such as Erythrocyte Sedimentation Rate (ESR) and C-Reactive Protein (CRP) to detect generalized inflammatory responses, along with Rheumatoid Factor (RF) and sometimes Anti-CCP to screen for autoimmune joint diseases. Additionally, Uric Acid levels are frequently measured to assess for gout, a condition notably prevalent in men. By analyzing these specific biomarkers, healthcare providers can differentiate between inflammatory and non-inflammatory joint pain, facilitating an accurate diagnosis and timely intervention to preserve long-term joint health.

An **Arthritis Profile B test** is an expanded, multi-parameter diagnostic panel designed to comprehensively evaluate complex joint disorders and autoimmune inflammatory conditions. In addition to core markers like **Rheumatoid Factor (RF)**, **C-Reactive Protein (CRP)**, and **Erythrocyte Sedimentation Rate (ESR)**, Profile B typically incorporates specialized biomarkers such as **Anti-CCP**, **Anti-Nuclear Antibodies (ANA)**, **ASO Titre**, **HLA-B27**, **Complement 3 (C3)**, and **Vitamin D levels**.
Clinicians order this extensive profile for patients presenting with persistent joint pain, morning stiffness, or suspected systemic autoimmune diseases like ankylosing spondylitis or lupus. It provides deep diagnostic insight to differentiate overlapping arthritic conditions and guide targeted therapy.